Comparison of the effects of herbal capsule Govarcin and Metoclopramide on Treatment of functional dyspepsia

Comparison of the effects of herbal capsule SOE HAZEMEH (Govarcin) and Metoclopramide on the quality of life in patients with functional dyspepsia

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190806044456N1

Enrollment

Registered

2019-12-08

Start date

2019-09-23

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dyspepsia. Functional dyspepsia

Interventions

Intervention 1: Intervention group consisted of vegetable indigestion capsule (Govarcin). This capsule contains Nigella sativa (20%), Satureja hortensis(10%), Thymus vulgaris(20%), Trachyspermum copti

Eligibility

Sex/Gender

All

Age

14 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients 14 to 65 years of age with any of the symptoms of functional dyspepsia normality of upper gastrointestinal endoscopic results normal abdominal ultrasound Satisfaction with research collaboration

Exclusion criteria

Exclusion criteria: Taking antipsychotic drugs Use of antidepressants Sensitivity to Metoclopramide

Design outcomes

Primary

Measure	Time frame
Postprandial fullness. Timepoint: Before taking the drug and 4 weeks after starting medication. Method of measurement: ROM III questionnaire.;Early Satiety. Timepoint: Before taking the drug and 4 weeks after starting medication. Method of measurement: ROM III questionnaire.;Abdominal pain. Timepoint: Before taking the drug and 4 weeks after starting medication. Method of measurement: Determination of epigastric pain according to VAS criteria and questionnaire ROM III.;Heartburn. Timepoint: Before taking the drug and 4 weeks after starting medication. Method of measurement: ROM III questionnaire.;Quality of Life. Timepoint: Before taking the drug and 4 weeks after starting medication. Method of measurement: ROM III questionnaire.	—

Measure

Time frame

Postprandial fullness. Timepoint: Before taking the drug and 4 weeks after starting medication. Method of measurement: ROM III questionnaire.;Early Satiety. Timepoint: Before taking the drug and 4 weeks after starting medication. Method of measurement: ROM III questionnaire.;Abdominal pain. Timepoint: Before taking the drug and 4 weeks after starting medication. Method of measurement: Determination of epigastric pain according to VAS criteria and questionnaire ROM III.;Heartburn. Timepoint: Before taking the drug and 4 weeks after starting medication. Method of measurement: ROM III questionnaire.;Quality of Life. Timepoint: Before taking the drug and 4 weeks after starting medication. Method of measurement: ROM III questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad Hormati

Ghoum University of Medical Sciences

hormatia113@gmail.com+98 25 3612 2058

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026